ADAM9 and hepatocellular carcinoma: On the other hand, treatment with interleukin (IL)-1β on HCC cell lines increased the expression of ADAM9 and sMICA, and the IL-1β-treated HCC cells became more resistant to the cytolytic activity of NK cells [42].